Featured News
-
ACLA Statement on District Court Opinion in Lawsuit Against HHS
Lawsuit targeted HHS’ unlawful implementation of 2014 Medicare legislation, regulatory guidance that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – Following the opinion from the U.S. District Court for the District of Columbia in ACLA v. Azar, Julie Khani, ACLA President, issued the following statement: “This is an extremely disappointing outcome for ACLA’s members and the millions of seniors they serveContinue Reading »... -
Press Release; ACLA Submits Comments to Proposed 2019 Medicare Payment Policies
... -
ACLA Comments on CY 2019 PFS Proposed Rule
... -
ACLA Calls on CMS to Address Questionable Medicare Utilization Practices Through Stronger ‘Stark Law’ Provisions
Washington, D.C. – In a new comment letter to the Centers for Medicare & Medicaid Services (CMS), the American Clinical Laboratory Association called on the agency to address the long-standing abuse of the physician self-referral law (“Stark Law”) that has lead to persistent overutilization of specific services across the Medicare program. While CMS’ Request For Information on the Stark Law largely centered on howContinue Reading »... -
AIM Coalition Urges CMS to Strengthen Medicare Self-Referral Provisions to Support Transition to Value-Based Care
Proposed Changes to Stark Law – Including Narrowing the In-Office Ancillary Services Exception – Would Save Medicare at Least $3.3 Billion Over Next Decade Washington, D.C. – The Medicare program could save at least $3.3 billion over the next decade by narrowing a persistent loophole in the physician self-referral law (“Stark Law”) that drives questionable utilization patterns for certain health services. The cost-savings proposalContinue Reading »... -
ACLA Urges Congressional Leaders to Advance New Regulatory Framework for Diagnostic Tests
In Comments to Congress, ACLA Cites Concerns with the FDA’s New Proposals for Diagnostic Reform Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) calls on Congressional leaders to enact a distinct regulatory framework for diagnostics – a key goal outlined in comments to Reps. Larry Bucshon (R-IN) and Diana DeGette (D-CO), and Sens. Orrin Hatch (R-UT) and Michael Bennet (D-CO). The commentsContinue Reading »... -
Diagnostic Reform Coalition Letter to the Hill regarding FDA Technical Assistance
... -
Leading Patient, Provider, Diagnostic and Laboratory Organizations Call on Congress to Protect Seniors from Medicare Lab Cuts
HHS’ flawed data collection system jeopardizes beneficiary access to critical lab services Washington, D.C. – With millions of Medicare beneficiaries facing year-over-year cuts to their Medicare lab access, more than 30 leading organizations representing patients, health care professionals, laboratories and diagnostic manufacturers urged Congressional leaders to take immediate action to prevent drastic reductions to beneficiaries’ care. The letter reiterates the serious concerns regarding theContinue Reading »... -
Market-Based in Practice, Not Just Theory
One of the driving forces in today’s health system is the goal of promoting and maintaining a competitive market for patients. In a “market-based” health system, consumers see the direct benefit of labs competing on quality, cost and services available – rather than an arbitrary, one-size-fits-all approach that fails to achieve any of these goals. In fact, that was one of the prevailing incentivesContinue Reading »... -
ACLA Statement on HHS OIG Report Regarding PAMA Cuts & Data Collection
Washington, D.C. – Following the release of today’s report from the U.S. Department of Health & Human Services (HHS) and the Office of Inspector General (OIG) regarding laboratory data collection under The Protecting Access to Medicare Act of 2014 (PAMA), Julie Khani, President of the American Clinical Laboratory Association (ACLA), released the following statement: “Today’s OIG report skirts the central issue: that HHS deliberatelyContinue Reading »...
